BACKGROUND: The purpose of this study was to report the efficacy of routine follow-up after head and neck cancer treatment. METHOD: Data for 520 patients with head and neck cancer registered with between 2002 and 2008 were reviewed retrospectively. RESULTS: The mean ± SD follow-up period taken into account was 34.7 ± 22.8 months. The pickup rate for recurrence using our follow-up protocol in this cohort was 1 in every 79 visits (1.26%). High pickup rates were observed in patients older than 70 years and patients with advanced T classification, whereas low pickup rates were observed in patients who had received treatment including surgery. The only factor on multivariate analysis to influence follow-up visits was surgical treatment (p = .043). CONCLUSION: Individualized and obligatory follow-up policy is desirable considering various factors, especially age, T classification, and whether treatment modality includes surgery or not.
BACKGROUND: The purpose of this study was to report the efficacy of routine follow-up after head and neck cancer treatment. METHOD: Data for 520 patients with head and neck cancer registered with between 2002 and 2008 were reviewed retrospectively. RESULTS: The mean ± SD follow-up period taken into account was 34.7 ± 22.8 months. The pickup rate for recurrence using our follow-up protocol in this cohort was 1 in every 79 visits (1.26%). High pickup rates were observed in patients older than 70 years and patients with advanced T classification, whereas low pickup rates were observed in patients who had received treatment including surgery. The only factor on multivariate analysis to influence follow-up visits was surgical treatment (p = .043). CONCLUSION: Individualized and obligatory follow-up policy is desirable considering various factors, especially age, T classification, and whether treatment modality includes surgery or not.
Authors: Haley K Perlow; Stephen J Ramey; Vincent Cassidy; Deukwoo Kwon; Benjamin Farnia; Elizabeth Nicolli; Michael A Samuels; Laura Freedman; Nagy Elsayyad; Raphael Yechieli; Stuart E Samuels Journal: Laryngoscope Date: 2018-12-24 Impact factor: 3.325
Authors: Maria T Brands; Elisabeth A J Smeekens; Robert P Takes; Johannes H A M Kaanders; Andre L M Verbeek; Matthias A W Merkx; Sandra M E Geurts Journal: Cancer Med Date: 2019-08-10 Impact factor: 4.452